• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇在人实体瘤中的渗透和蓄积的决定因素。

Determinants of paclitaxel penetration and accumulation in human solid tumor.

作者信息

Kuh H J, Jang S H, Wientjes M G, Weaver J R, Au J L

机构信息

College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

出版信息

J Pharmacol Exp Ther. 1999 Aug;290(2):871-80.

PMID:10411604
Abstract

The present study examined the determinants of the penetration and accumulation of [(3)H]paclitaxel (12-12,000 nM) in three-dimensional histocultures of patient tumors and of a human xenograft tumor in mice. The results showed 1) significant and saturable drug accumulation in tumors, 2) extensive drug retention in tumors, and 3) a slower penetration but a more extensive accumulation in the xenograft tumor compared with patient tumors. Drug penetration was not rate-limited by drug diffusion from medium through the matrix supporting the histocultures. The difference in the expression of the mdr1 P-glycoprotein did not fully account for the difference in the drug accumulation in xenograft and patient tumors. Autoradiography and imaging were used to evaluate the spatial relationship between tumor architecture, tumor cell distribution, and drug distribution as a function of time and initial drug concentration in culture medium. The tumor cell density and the kinetics of drug-induced apoptosis were also evaluated. The results indicate that a high tumor cell density is a barrier to paclitaxel penetration and that the apoptotic effect of paclitaxel enhances its penetration in solid tumor. These factors are responsible for the time- and concentration-dependent drug penetration rate, with drug penetration confined to the periphery until apoptosis and reduction of epithelial cell density occurred at 24 h, after which time paclitaxel penetrated the inner parts of the tumor.

摘要

本研究检测了[(3)H]紫杉醇(12 - 12,000 nM)在患者肿瘤的三维组织培养物以及小鼠体内人异种移植肿瘤中的渗透和蓄积的决定因素。结果显示:1)肿瘤中存在显著且可饱和的药物蓄积;2)药物在肿瘤中大量滞留;3)与患者肿瘤相比,异种移植肿瘤中的药物渗透较慢,但蓄积更广泛。药物渗透并非由药物从培养基通过支持组织培养的基质扩散所限速。mdr1 P - 糖蛋白表达的差异并不能完全解释异种移植肿瘤和患者肿瘤中药物蓄积的差异。利用放射自显影和成像技术评估肿瘤结构、肿瘤细胞分布与药物分布之间的空间关系,该关系是时间以及培养基中初始药物浓度的函数。还评估了肿瘤细胞密度以及药物诱导凋亡的动力学。结果表明,高肿瘤细胞密度是紫杉醇渗透的障碍,且紫杉醇的凋亡作用增强了其在实体瘤中的渗透。这些因素导致了药物渗透速率的时间和浓度依赖性,在24小时凋亡和上皮细胞密度降低发生之前,药物渗透局限于周边区域,此后紫杉醇渗透到肿瘤内部。

相似文献

1
Determinants of paclitaxel penetration and accumulation in human solid tumor.紫杉醇在人实体瘤中的渗透和蓄积的决定因素。
J Pharmacol Exp Ther. 1999 Aug;290(2):871-80.
2
Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.通过诱导凋亡预处理增强紫杉醇向实体瘤的递送:治疗方案的影响
J Pharmacol Exp Ther. 2001 Mar;296(3):1035-42.
3
Determinants of paclitaxel uptake, accumulation and retention in solid tumors.
Invest New Drugs. 2001 May;19(2):113-23. doi: 10.1023/a:1010662413174.
4
Computational model of intracellular pharmacokinetics of paclitaxel.
J Pharmacol Exp Ther. 2000 Jun;293(3):761-70.
5
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.通过将天然脂肪酸与紫杉醇共价偶联实现肿瘤靶向
Clin Cancer Res. 2001 Oct;7(10):3229-38.
6
Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors.腹腔内持续递送紫杉醇对卵巢肿瘤中P-糖蛋白表达的影响。
J Control Release. 2007 Jan 22;117(1):20-7. doi: 10.1016/j.jconrel.2006.10.007. Epub 2006 Oct 7.
7
A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.一种用于评估全细胞药物外排动力学的流动池测定法:对过表达P-糖蛋白的CCRF-CEM白血病细胞中紫杉醇外排的分析。
Drug Metab Dispos. 2001 Feb;29(2):103-10.
8
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.紫杉醇纳米颗粒抑制卵巢癌异种移植瘤的生长并增强淋巴靶向性。
Cancer Chemother Pharmacol. 2007 Feb;59(2):175-81. doi: 10.1007/s00280-006-0256-z. Epub 2006 May 23.
9
The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.P-糖蛋白对紫杉醇在小鼠脑及脑肿瘤中分布的影响。
Cancer Res. 2003 Aug 15;63(16):5114-7.
10
Kinetics of P-glycoprotein-mediated efflux of paclitaxel.P-糖蛋白介导的紫杉醇外排动力学
J Pharmacol Exp Ther. 2001 Sep;298(3):1236-42.

引用本文的文献

1
Inhaled Chemotherapy.吸入式化疗
J Aerosol Med Pulm Drug Deliv. 2025 Apr;38(2):90-101. doi: 10.1089/jamp.2025.19211.js.
2
The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models.P-糖蛋白抑制剂艾拉司群在二维和三维细胞培养模型中使耐紫杉醇卵巢癌细胞系对细胞毒性药物重新致敏中的作用
Int J Mol Sci. 2025 Jan 28;26(3):1124. doi: 10.3390/ijms26031124.
3
Bidirectional chemotherapy long-term as a treatment strategy for peritoneal metastases.
双向化疗长期作为腹膜转移的一种治疗策略。
Transl Cancer Res. 2024 Feb 29;13(2):490-495. doi: 10.21037/tcr-23-2039. Epub 2024 Feb 20.
4
Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors.实体肿瘤治疗中药物递送所面临的挑战与机遇
Oncol Rev. 2023 Aug 30;17:10577. doi: 10.3389/or.2023.10577. eCollection 2023.
5
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice.体内评估 6b 针对裸鼠人源异种移植肿瘤的非共价结合的咪唑并[1,2-]喹喔啉类表皮生长因子受体抑制剂的抗癌活性。
Molecules. 2022 Aug 28;27(17):5540. doi: 10.3390/molecules27175540.
6
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.持续超治疗剂量紫杉醇递送增强不可逆转的肉瘤细胞死亡。
Mol Cancer Ther. 2022 Nov 3;21(11):1663-1673. doi: 10.1158/1535-7163.MCT-21-0750.
7
PLGA Core-Shell Nano/Microparticle Delivery System for Biomedical Application.用于生物医学应用的聚乳酸-羟基乙酸共聚物核壳纳米/微粒递送系统
Polymers (Basel). 2021 Oct 10;13(20):3471. doi: 10.3390/polym13203471.
8
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects.腹腔内注射紫杉醇:药理学、临床结果及未来前景。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S231-S239. doi: 10.21037/jgo-2020-03.
9
Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis.细胞减灭术联合 HIPEC 与不联合 NIPEC 治疗恶性腹膜间皮瘤:倾向评分匹配分析。
Ann Surg Oncol. 2021 Nov;28(12):7109-7117. doi: 10.1245/s10434-021-10048-4. Epub 2021 May 3.
10
Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.脂质/聚丙烯酸酯包覆的介孔硅纳米粒子用于三氧化二砷/紫杉醇的双 pH 响应共递送,以对抗乳腺癌细胞。
Acta Pharmacol Sin. 2021 May;42(5):832-842. doi: 10.1038/s41401-021-00648-x. Epub 2021 Apr 6.